Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 5821-5830 Newer>

The Motley Fool February 16, 2005	Earnings Report Basics If you're going to be a savvy investor, you need to know about -- and read -- quarterly earnings reports that companies issue.
The Motley Fool February 16, 2005 Rick Aristotle Munarriz	I Can't Bear to Watch Vermont Teddy Bear didn't look so cuddly after yesterday's tumble.
The Motley Fool February 16, 2005 Rick Aristotle Munarriz	Tying the Knot With The Knot The online wedding specialist's net revenue for all of 2004 rose by a mere 13% to hit $41.4 million, while earnings of $0.06 per share were flat with last year's showing. But there's more to the numbers than that.
The Motley Fool February 16, 2005 Selena Maranjian	Just Buy a Few Shares Don't think that buying fewer than 100 shares is costly. It needn't be.
The Motley Fool February 15, 2005 W.D. Crotty	Dear, Dear, Deere Deere's numbers are good, but the market seems to have expected a better outlook.
The Motley Fool February 15, 2005 Rich Smith	GM's Italian Fiat-sco The automaker is free from a relationship that probably never should have happened.
The Motley Fool February 15, 2005 Stephen D. Simpson	Genesee Rides Smooth Rails Short-line railroad operator continues to prosper by focusing on profitable and growing routes.
The Motley Fool February 15, 2005 Tim Beyers	ServiceMaster Serves Cash The exterminator-cum-lawn care company boosts cash flow by $500 million over last year. Good companies with steady cash flows are rarely available at good prices. In that sense, ServiceMaster is about as good as it gets.
The Motley Fool February 15, 2005 Alyce Lomax	Is Jeeves Getting Firefoxy? Rumors abound linking Ask Jeeves and Firefox. Investors need only sit on the sidelines and wonder just how close to the browser Ask Jeeves might get.
The Motley Fool February 15, 2005 Charly Travers	Searching for Cheap Biotechs Can a stock screen turn up a winner? Remember, the screen just gives a short list of potential ideas and some guidance as to where a good place to look may be. But it is not a replacement for doing research on a company's drug programs and management team.
<Older 5821-5830 Newer> Return to current articles.